Αποτελέσματα Αναζήτησης
The purpose of this guideline is to improve early recognition of obesity hypoventilation syndrome (OHS) and advise clinicians concerning the management of OHS, with the goal of reducing variability in clinical practice.
- Login
The purpose of this guideline is to improve early...
- Forgotten your password
We would like to show you a description here but the site...
- Login
CPAP is considered the first-line treatment modality for OHS phenotype with concomitant severe obstructive sleep apnoea, whereas NIV is preferred in the minority of OHS patients with hypoventilation during sleep with no or milder forms of obstructive sleep apnoea (approximately <30% of OHS patients).
18 Ιαν 2024 · FIRST-LINE THERAPY. Noninvasive positive airway pressure (PAP) together with weight loss are the initial first-line therapies for patients with OHS [1]. A comprehensive and multidisciplinary approach utilizing experts in obesity, sleep, and pulmonary medicine is recommended.
11 Ιαν 2024 · Objectives: Identify the etiology of obesity hypoventilation syndrome. Review the presentation of a patient with obesity hypoventilation syndrome. Outline the management options available for obesity hypoventilation syndrome.
1 Νοε 2020 · Noninvasive ventilation versus CPAP as initial treatment of obesity hypoventilation syndrome: a systematic review
11 Απρ 2019 · This is a review of the current understanding of the pathophysiology behind the development of daytime hypercapnia in a subset of obese patients. It provides an overview of the recent evidence to guide physicians in the diagnosis and treatment of patients with obesity hypoventilation syndrome (OHS).
Available treatment options include noninvasive positive airway pressure therapies and weight loss. Introduction.